Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Marianne M Stanford & Grant McFadden. (2007) Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer. Expert Opinion on Biological Therapy 7:9, pages 1415-1425.
Read now
Read now
Articles from other publishers (21)
Nina Bono, Giulio Saroglia, Stefania Marcuzzo, Eleonora Giagnorio, Giuseppe Lauria, Elena Rosini, Luigi De Nardo, Athanassia Athanassiou, Gabriele Candiani & Giovanni Perotto. (2022) Silk fibroin microgels as a platform for cell microencapsulation. Journal of Materials Science: Materials in Medicine 34:1.
Crossref
Crossref
Hanwei Huang, Mengchi Sun, Mingyang Liu, Siwei Pan, Pengfei Liu, Zhenguo Cheng, Jia Li, Huimian Xu, Funan Liu & Zhiqing Pang. (2022) Full encapsulation of oncolytic virus using hybrid erythroctye-liposome membranes for augmented anti-refractory tumor effectiveness. Nano Today 47, pages 101671.
Crossref
Crossref
Satoshi Yamaguchi, Kazuki Chujo, Noriyuki Ohashi, Kosuke Minamihata & Teruyuki Nagamune. (2022) Photo‐Degradable Protein‐Polymer Hybrid Shells for Caging Living Cells. Chemistry – A European Journal 28:12.
Crossref
Crossref
Noraini Abd-Aziz & Chit Laa Poh. (2021) Development of oncolytic viruses for cancer therapy. Translational Research 237, pages 98-123.
Crossref
Crossref
Amir Sasan Mozaffari Nejad, Tehjeeb Noor, Ziaul Haque Munim, Mohammad Yousef Alikhani & Amir Ghaemi. (2021) A bibliometric review of oncolytic virus research as a novel approach for cancer therapy. Virology Journal 18:1.
Crossref
Crossref
Abdolreza Osali, Mina Zhiani, Mahnaz Ghaebi, Mohammadreza Meymanat & Abdolreza Esmaeilzadeh. (2020) Multidirectional Strategies for Targeted Delivery of Oncolytic Viruses by Tumor Infiltrating Immune Cells. Pharmacological Research 161, pages 105094.
Crossref
Crossref
Yang Bai, Peng Hui, Xiaoyu Du & Xing Su. (2019) Updates to the antitumor mechanism of oncolytic virus. Thoracic Cancer 10:5, pages 1031-1035.
Crossref
Crossref
Neil S. Forbes, Robert S. Coffin, Liang Deng, Laura Evgin, Steve Fiering, Matthew Giacalone, Claudia Gravekamp, James L. Gulley, Hal Gunn, Robert M. Hoffman, Balveen Kaur, Ke Liu, Herbert Kim Lyerly, Ariel E. Marciscano, Eddie Moradian, Sheryl Ruppel, Daniel A. Saltzman, Peter J. Tattersall, Steve Thorne, Richard G. Vile, Halle Huihong Zhang, Shibin Zhou & Grant McFadden. (2018) White paper on microbial anti-cancer therapy and prevention. Journal for ImmunoTherapy of Cancer 6:1.
Crossref
Crossref
Jahangir Ahmed, Ming Yuan, Ghassan Alusi, Nicholas R. Lemoine & Yaohe Wang. 2014. Gene Therapy of Cancer. Gene Therapy of Cancer
225
238
.
Daniel Y. Sze, Tony R. Reid & Steven C. Rose. (2013) Oncolytic Virotherapy. Journal of Vascular and Interventional Radiology 24:8, pages 1115-1122.
Crossref
Crossref
Arun Kumar, Heidi Mansour, Adam Friedman & Eric BloughNiketa Dixit, Mark Glaum, Arun Kumar & Don Cameron. 2013. Nanomedicine in Drug Delivery. Nanomedicine in Drug Delivery
75
88
.
Padma Sampath, Jun Li, Weizhou Hou, Hannah Chen, David L Bartlett & Steve H Thorne. (2013) Crosstalk Between Immune Cell and Oncolytic Vaccinia Therapy Enhances Tumor Trafficking and Antitumor Effects. Molecular Therapy 21:3, pages 620-628.
Crossref
Crossref
Steve H. Thorne. (2011) Immunotherapeutic potential of oncolytic vaccinia virus. Immunologic Research 50:2-3, pages 286-293.
Crossref
Crossref
Aya Saito, Naoya Morishita, Chihomi Mitsuoka, Shunichi Kitajima, Katsuyuki Hamada, Kyung‐Mi Lee, Masato Kawabata, Masato Fujisawa & Toshiro Shirakawa. (2011) Intravenous injection of irradiated tumor cell vaccine carrying oncolytic adenovirus suppressed the growth of multiple lung tumors in a mouse squamous cell carcinoma model. The Journal of Gene Medicine 13:6, pages 353-361.
Crossref
Crossref
Candice Willmon, Kevin Harrington, Timothy Kottke, Robin Prestwich, Alan Melcher & Richard Vile. (2009) Cell Carriers for Oncolytic Viruses: Fed Ex for Cancer Therapy. Molecular Therapy 17:10, pages 1667-1676.
Crossref
Crossref
Steve H. Thorne, Yoram Barak, Wenchuan Liang, Michael H. Bachmann, Jianghong Rao, Christopher H. Contag & A. Matin. (2009) CNOB/ChrR6, a new prodrug enzyme cancer chemotherapy. Molecular Cancer Therapeutics 8:2, pages 333-341.
Crossref
Crossref
Murielle Mimeault & Surinder K. Batra. 2010. Stem Cell Biology in Health and Disease. Stem Cell Biology in Health and Disease
385
421
.
M Mimeault, R Hauke & SK Batra. (2007) Recent Advances on the Molecular Mechanisms Involved in the Drug Resistance of Cancer Cells and Novel Targeting Therapies. Clinical Pharmacology & Therapeutics 83:5, pages 673-691.
Crossref
Crossref
S H Thorne & C H Contag. (2008) Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery. Gene Therapy 15:10, pages 753-758.
Crossref
Crossref
Z. Sheng Guo, Stephen H. Thorne & David L. Bartlett. (2008) Oncolytic virotherapy: Molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1785:2, pages 217-231.
Crossref
Crossref
Wei Deng & Jun Jia. (2008) Endothelial progenitor cells as cellular vehicles to deliver oncolytic virus therapies to metastatic tumors: The ?Trojan horse? approach. Medical Hypotheses 70:4, pages 842-844.
Crossref
Crossref